Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Gynecology | Internal Medicine | Oncology | Pathology | Radiology | Surgery | Journal

Back to Journal Articles

Low Ovarian Cancer Detection Rate by Symptoms Alone

Last Updated: July 16, 2009.

 

Transvaginal ultrasound may be a more sensitive way to look for ovarian malignancy

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Using symptoms alone only identifies 20 percent of women with malignant tumors, but a negative result on the symptoms index combined with a negative ultrasound result is highly indicative of a benign mass, according to a study published online July 14 in Cancer.

THURSDAY, July 16 (HealthDay News) -- Using symptoms alone only identifies 20 percent of women with malignant tumors, but a negative result on the symptoms index combined with a negative ultrasound result is highly indicative of a benign mass, according to a study published online July 14 in Cancer.

Edward J. Pavlik, Ph.D., of the University of Kentucky Medical Center in Lexington, and colleagues conducted a study of 272 women selected from 31,748 women enrolled in annual transvaginal screening for ovarian cancer, to gather information on symptoms of ovarian cancer correlated with ultrasound and surgical pathology. Symptom information was gathered through a patient questionnaire, including a question regarding the patients' confidence levels about their answers, to identify potential recall bias.

The researchers found that, although ovarian cancer could be identified by symptoms, transvaginal ultrasound was better at detecting malignancies, with sensitivity of 73.3 percent versus 20 percent for symptoms. However, the analysis of symptoms was better than transvaginal ultrasound for the diagnosis of benign tumors (91.3 versus 74.4 percent).

"Despite the authors attempts to compensate for this potential [patient recall] bias, they cannot answer their own study question with the current study design," writes the author of an accompanying editorial. "Prospective collection of symptoms information from women who are followed in a prospective screening program is the more appropriate way to study the potential benefit of both screening tools. The authors' conclusions regarding the minimal incremental gains they observed should not dissuade others from further study of this important research question."

The study was supported by grants from the Telford Foundation and the Department of Health and Human Services in Kentucky.

Abstract
Full Text (subscription or payment may be required)
Editorial

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Drug Groups Causing Liver Transplantation Identified Next: Intensive Statins Beneficial in Acute Coronary Syndrome

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2013
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.